Please assess the completion status of the following clinical trial:

Trial Title: Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator HA Coated Modular Femoral Stems

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subject has undergone primary THA for any of the following:~* Non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, ankylosis, protrusio acetabuli, or painful hip dysplasia;~* Inflammatory degenerative joint disease such as rheumatoid arthritis; or~* Correction of functional deformity~* Subject is implanted with the specified combination of components~* Subject is willing and able to complete required study visits or assessments~Previously implanted bilateral subjects can have both THAs enrolled in the study provided: 1) the specified combination of components were implanted in both, 2) all other aspects of the Inclusion/Exclusion Criteria are satisfied, 3) enrollment does not exceed the subject count specified in the Investigator Agreement, and 4) the subject agrees to a second Informed Consent document specific to the second THA. Prospective enrollment of a previously unimplanted hip is not permitted in this study.~Exclusion Criteria:~* Subjects skeletally immature (less than 21 years of age) at time of primary THA surgery~* Subjects currently enrolled in another clinical study which could affect the endpoints of this protocol~* Subjects unwilling to sign the Informed Consent document~* Subjects with substance abuse issues~* Subjects who are incarcerated

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PROFEMUR® Gladiator HA Coated Stem (Type: None): Single study group previously implanted with a primary PROFEMUR® Gladiator HA Coated Modular Femoral Stem (HA = Hydroxyapatite)

Based on this trial design, predict the completion outcome and termination type (if applicable).